Lonza’s Portsmouth facility has committed to manufacturing 100 million doses a year of the active ingredient used in the Moderna vaccine. It commenced large-scale production of the vaccine in ...

The products currently manufactured at the site by Roche will be supplied by Lonza, with committed volumes over the medium term, phasing out over time as the site transitions to serve alternative ...

Lonza Group AG / Key word (s): Acquisition Lonza Completes Acquisition of Large-Scale Biologics Site in Vacaville (US) from Roche 01.10.2024 / 16:45 CET/CEST The Vacaville site is one of the ...

As the transaction is expected to be accretive to sales growth, Lonza has updated its Mid-Term Guidance 2024 - 2028. Its sales growth range was set at 11 - 13% CAGR in CER, and has now been ...

Lonza Group AG agreed to buy a manufacturing facility in the US from Roche Holding AG for $1.2 billion, adding production capacity in the rapidly growing field of biologic medicines.

We also anticipate Lonza's cell and gene segment will drive long-term growth for the company, as it benefits from rising demand for these novel therapies, and their highly complex manufacturing ...

About Lonza Lonza is one of the world's leading suppliers to the pharmaceutical, healthcare and life science industries. Products and services span its customers' needs from research to final ...

Lonza, the Swiss Biotech firm that purchased Vacaville’s Genentech plant from Roche in 2024, released a streamlined operating model and invitations to its Annual General Meeting in Basel ...

Firstly, Lonza Vacaville's revenue recognition will start in 2025, and we now apply a 17.5% sales growth for next year for a total consideration of CHF 400 million.

In 2022, Lonza spent about 29% of sales on capital expenditures, and the company is on track to spend about 30% in 2023. Of the company's annual capital expenditures, around 70%-80% is invested in ...

Lonza Biologics will break ground Aug. 30 on a new 130,000-square-foot facility at the Pease International Tradeport in Portsmouth that it will finance and construct with Boston-based Vertex ...

Lonza Group was founded in Switzerland in 1897 and operates in more than 35 countries worldwide. In full year 2019, sales were CHF (Swiss Francs) 5.9 billion and core EBITDA was CHF 1.6 billion.